From the "About PharmAust" section at the bottom of the announcement :
"The Neurodegenerative Disease Market size is estimated at USD 55.12 billion in 2024, and is expected to reach USD 77.82 billion by 2029, growing at a CAGR of 7.14% during the forecast period (2024-2029)²."
Ongoing successful outcomes for MPL in the Neuro Disease space may bring to mind the 1974-75 winner of Melbourne Cup - THINK BIG !!
Ann: PharmAust makes Head of Manufacturing appointment, page-20
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.005(2.38%) |
Mkt cap ! $83.14M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 21.0¢ | $84.12K | 391.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 78929 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 119109 | 3 |
View Market Depth
| Last trade - 11.20am 25/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |